Glenmark Pharma

Heading

Posted by : NAUGHTY007
Price when posted : BSE: Rs 246.85 ( 0.35 % ), NSE: Rs. 247.10 ( 0.65 % )

tom nifty will be weak again-will tank tomm...

Support at 240.

Posted by : jonas
Price when posted : BSE: Rs 246.85 ( 0.35 % ), NSE: Rs. 247.10 ( 0.65 % )

held out well today with a good support at 240....

Heading

Posted by : jonas
Price when posted : BSE: Rs 246.00 ( 1.49 % ), NSE: Rs. 245.50 ( 1.01 % )

pharma n health care sector is showing good strength.

Ranbaxy, Cipla, Piramal n Glenmark all gained by @ 2% yesterday.

......

Heading

Posted by : NAUGHTY007
Price when posted : BSE: Rs 246.00 ( 1.49 % ), NSE: Rs. 245.50 ( 1.01 % )

i think the share will dip to 237 tomm...

Target 275

Posted by : jonas
Price when posted : BSE: Rs 242.40 ( 5.37 % ), NSE: Rs. 243.05 ( 6.09 % )

it may now move up to 275 n beyond.

keep SL at 235.

......

Ref: EMKAY GLOBAL message on GLENMARK

Posted by : ar_akm
Price when posted : BSE: Rs 242.40 ( 5.37 % ), NSE: Rs. 243.05 ( 6.09 % )

what is the good level to buy?...

short term target achieved

Posted by : wife
Price when posted : BSE: Rs 242.40 ( 5.37 % ), NSE: Rs. 243.05 ( 6.09 % )

Short term target on this stock is achieved. If market corrects so will this stock, target 220....

Ref: EMKAY GLOBAL message on GLENMARK

Posted by : Guest
Price when posted : BSE: Rs 242.40 ( 5.37 % ), NSE: Rs. 243.05 ( 6.09 % )

so weird man.haha i know its trading above 45 nowdays.... its a good buy...

Ref: EMKAY GLOBAL message on GLENMARK

Posted by : Guest
Price when posted : BSE: Rs 242.15 ( 5.26 % ), NSE: Rs. 243.00 ( 6.07 % )

Sir, You have asked to hold glenmark to target of 214. It is already trading above 240 at the moment. Kindly advise...

Finding difficult to cross 234

Posted by : wife
Price when posted : BSE: Rs 233.00 ( 1.28 % ), NSE: Rs. 233.00 ( 1.70 % )

The stock if sustains above the present levels can touch 250 technically. May it is consolidating at the present level....

NSE Announcements on Glenmark

Posted by : MMB Messenger
Price when posted : [Glenmark - BSE:Rs. 234.50 NSE:Rs. 203.60 when posted]

Glenmark Pharmaceuticals Ltd. has informed the Exchange regarding a press release dated November 16, 2009, titled "Glenmark Pharmaceuticals outlicenses a specialty pharmaceutical product to medicis pharmaceutical for the North America Region". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). ...

NSE Announcements on Glenmark

Posted by : MMB Messenger
Price when posted : [Glenmark - BSE:Rs. 234.50 NSE:Rs. 203.60 when posted]

Glenmark Pharmaceuticals Ltd. has informed the Exchange regarding a press release dated November 16, 2009, titled "Glenmark Generics announces the settlement of Para IV litigations with Medicis Pharmaceutical Corporation". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements)....

NSE Announcements on Glenmark

Posted by : MMB Messenger
Price when posted : [Glenmark - BSE:Rs. 234.50 NSE:Rs. 203.60 when posted]

Glenmark Pharmaceuticals Ltd. has informed the Exchange regarding a press release dated November 14, 2009, titled "Glenmark Generics receives ANDA approval from US-FDA for Ciclopirox Olamine Cream". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements)....

BSE Announcements on Glenmark

Posted by : MMB Messenger
Price when posted : [Glenmark - BSE:Rs. 235.70 NSE:Rs. 203.60 when posted]

Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated November 16, 2009 titled "Glenmark Generics announces the settlement of Para IV litigations with
Medicis Pharmaceutical Corporation"...

BSE Announcements on Glenmark

Posted by : MMB Messenger
Price when posted : [Glenmark - BSE:Rs. 235.70 NSE:Rs. 203.60 when posted]

Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated November 16, 2009 titled "Glenmark Pharmaceuticals outlicenses a specialty pharmaceutical product
to Medicis Pharmaceutical for the North America Region"...